Sunday, August 20, 2017

Good News for Bristol-Myers

February 18, 2011 by  
Filed under Depression

Bristol-Myers' product portfolio was strengthened further with the FDA clearing the schizophrenia and depression drug Abilify, for an additional indication.

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!